19 June 2013
Keywords: roche, granted, tamiflu, priority, review, hoffmann-la, been
Article | 16 September 1999
Hoffmann-La Roche has been granted priority review from HealthCanada for its influenza drug Tamiflu (oseltamavir). Meanwhile, the firm
says it ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 September 1999
9 September 1999
23 September 1999
© 2013 thepharmaletter.com